1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc.

THMO
ThermoGenesis Holdings, Inc.US flagOther OTC
0.00
USD
- -
- -
1,585.00Market Cap
ThermoGenesis Holdings, Inc.
THMO
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
FRC
14,177
12,724.29
14,819
14,216.28
10,446.46
9,783.77
5,938.71
3,578.41
1,783.11
659.18
236.55
207.57
69.6
35.46
10.11
3.99
3.2
Revenue per Share
-5,930.88
-5,494.86
-3,333.12
-1,559.54
-2,738.06
-1,680.83
-3,206.17
-3,312.96
-2,778.48
-1,320.4
-971.34
-151.09
-116.79
-43.41
-10.87
-7.59
-4.91
Basic EPS, GAAP
-5,791.34
-5,652.96
-2,842.11
-1,270.96
-2,133.44
-1,678.65
-2,910.85
-2,375.42
-1,438.71
-327.43
-170.78
-51.86
-102.81
-25.25
-7.02
-1.57
-1.2
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-57,979.97
-63,203.73
-66,455.71
-64,461.12
-61,004.39
-62,186.82
-45,609.96
-30,709.79
-23,357.1
-8,411.48
-5,562.34
-3,769.33
-1,809.11
-1,009.64
-256.66
-120
-95.21
Book Value per Share
19,718.99
14,430.59
11,411.42
12,207.17
8,557.39
7,253.81
5,020.8
91.9
-260.54
-114.5
106.61
-21.19
26.65
4.95
1.21
-1.51
-0.36
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
2
3
Basic Weighted Avg Shares
22
20
23
23
19
18
16
16
12
15
10
13
10
9
10
9
10
Sales/Revenue/Turnover
-47.24
-44.34
-22.76
-12.12
-28.28
-29.09
-56.55
-92.63
-91.08
-62.37
-108.19
-36.28
-91.29
-77.8
-59.08
-69.6
-63.33
Operating Margin (%)
1
- -
- -
- -
1
1
1
1
1
1
1
1
1
1
1
1
1
Depreciation Expense
-9
-9
-5
-3
-5
-3
-9
-15
-19
-29
-40
-9
-16
-11
-11
-18
-15
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-41.83
-43.18
-22.49
-10.97
-26.21
-17.18
-53.99
-92.58
-155.82
-200.31
-410.63
-72.79
-167.81
-122.43
-107.51
-190.31
-153.43
Profit Margin (%)
30
21
17
19
14
11
19
5
7
7
2
3
9
9
-1
-7
-4
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
2
4
1
6
7
10
4
3
3
LT Debt
31
22
18
20
16
13
49
35
32
31
7
1
6
3
3
-4
-1
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'23
Dec'23
Mar'24
ST Debt
5
8
4
LT Borrowings
- -
- -
- -
LT Finance Leases
3
3
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
4
8
Market Capitalization
3
1
2

Working Capital

FRC

•

in mil. unless spec.
Sep'23
Dec'23
Mar'24
Total Current Assets
7
5
4
Cash, Cash Equivalents & STI
4
2
1
Accounts Receivable, Net
- -
1
1
Inventories
2
1
1
Total Current Liabilities
9
12
8
Payables & Accruals
1
2
2
ST Debt
5
8
4
Deferred Revenue
1
1
1

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
34.95%
40.46%
-207.85%
Free Cash Flow
34.76%
39.06%
-48.91%
Net Income, GAAP
39.41%
4.84%
59.49%
Sales/Revenue/Turnover
-4.01%
1.57%
-9.9%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
3
3
2
3
10
2023
3
2
2
2
9
2024
3
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-6.99
-8.98
-4.66
- -
-10.87
2023
-4.07
-0.91
-1.44
- -
-7.59
2024
-0.46
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Similar Companies
Sonova Holding AG (SONVY)
Tivic Health Systems, Inc. (TIVC)
Kelyniam Global, Inc. (KLYG)
Hamilton Thorne Ltd. (HTLZF)
Beyond Air, Inc. (XAIR)
Avisa Diagnostics Inc. (AVBT.CN)
Business
ThermoGenesis Holdings, Inc. (THMO) develops, manufactures, and sells medical devices and services focused on cell and cell therapy processing for the regenerative medicine industry. The company offers the BioArchive System for automated cryopreservation of hematopoietic stem cells; the semi-automated ThermoGenesis X-Series for cell washing, culture, and formulation; the sterile processing disposable AXP II for collecting and concentrating stem cells; and related services including automated processing, cryopreservation, and cell therapy logistics. These products support cord blood banks, transplant centers, and cell therapy developers worldwide. ThermoGenesis Holdings, Inc., founded in 1986, is headquartered in Rancho Cordova, California, and operates primarily in the United States with distribution in Europe and Asia. In recent developments, the company has expanded its strategic focus on point-of-care cell therapy solutions through enhanced partnerships with leading regenerative medicine firms and the launch of next-generation disposable kits for its X-Series platform in 2024.

Company News

APIChat

  • globenewswire.com

    CitrusBurn Analyzed (INSIDER REPORT) Does Citrus Burn Natural Weight Loss Supplement Really Work? Achieves 74% Thermogenesis Increase in Clinical Studies

  • globenewswire.com

    The Ice Water Hack: How Aqua Sculpt Boosts Thermogenesis for Fat Loss

  • globenewswire.com

    Ice Water Hack: How Aqua Sculpt Improves Thermogenesis for Weight Loss

  • investorplace.com

    Why Is ThermoGenesis (THMO) Stock Down 37% Today?

  • seekingalpha.com

    ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript

  • prnewswire.com

    ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update

  • prnewswire.com

    ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update

  • prnewswire.com

    ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento

  • prnewswire.com

    ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference

  • seekingalpha.com

    Thermogenesis Holdings, Inc. (THMO) Q2 2023 Earnings Call Transcript

  • prnewswire.com

    ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update

  • prnewswire.com

    ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update

  • prnewswire.com

    ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu

  • seekingalpha.com

    ThermoGenesis Holdings, Inc. (THMO) Q1 2023 Earnings Call Transcript

  • investorplace.com

    Why Is ThermoGenesis (THMO) Stock Up 54% Today?

  • fool.com

    Why ThermoGenesis Stock Is Soaring Wednesday

  • investorplace.com

    THMO Stock Alert: Why ThermoGenesis Is Up 95% Today

  • seekingalpha.com

    ThermoGenesis Holdings, Inc. (THMO) CEO Dr. Chris Xu on Q3 2022 Results - Earnings Call Transcript

  • zacks.com

    ThermoGenesis Holdings, Inc. (THMO) Reports Q3 Loss, Misses Revenue Estimates

  • prnewswire.com

    ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2022 and Provide a Corporate Strategic Update